Results 11 to 20 of about 331,719 (291)
Human growth hormone therapy – in three stages: past, present, and future [PDF]
Pediatric Endocrinology, Diabetes and MetabolismMaciej Hilczer, Mieczysław Walczak
doaj +2 more sources
Orphanet Journal of Rare Diseases, 2023 Background Somatropin treatment is indicated in a variety of disorders including growth hormone (GH) deficiency, Prader–Willi and Turner syndrome, chronic renal insufficiency and others. To date, almost all studies have been limited to single GH products,
Dirk Schnabel +6 more
doaj +1 more source
Effects of human growth hormone on gonadotropin-releasing hormone neurons in mice [PDF]
Korean Journal of Pediatrics, 2010 PurposeRecombinant human growth hormone (rhGH) has been widely used to treat short stature. However, there are some concerns that growth hormone treatment may induce skeletal maturation and early onset of puberty.
Janardhan P. Bhattarai +3 more
doaj +1 more source
Effectiveness of Recombinant Human Growth Hormone for Pharyngocutaneous Fistula Closure [PDF]
Clinical and Experimental Otorhinolaryngology, 2015 ObjectivesIn laryngeal cancer, which comprises 25% of head and neck cancer, chemotherapy has come into prominence with the increase in organ-protective treatments.
Nurten Kucuk +5 more
doaj +1 more source
Perspectives on long-acting growth hormone therapy in children and adults
Archives of Endocrinology and Metabolism, 2020 Growth hormone therapy with daily injections of recombinant human growth hormone has been available since 1985, and is shown to be safe and effective treatment for short stature in children and for adult growth hormone deficiency. In an effort to produce
Rayhan A. Lal, Andrew R. Hoffman
doaj +1 more source
Short Stature in children: Review Article
SVU - International Journal of Medical Sciences, 2023 Background: Humans' final adult height is influenced by a variety of factors. A common paediatric endocrine issue, short stature has a variety of reasons, but normal variations account for the majority of cases.
Ahmed El-Abd Ahmed +3 more
doaj +1 more source
Italian Journal of Pediatrics, 2019 Background The treatment with recombinant human growth hormone in patients affected by Mucopolysaccharidoses (MPS) is considered whenever a concurrent diagnosis of growth hormone deficiency is demonstrated. The short- and long-term effects of recombinant
A. Cattoni +5 more
doaj +1 more source
Déficit de hormona de crecimiento: influencia de la pubertad en la respuesta al tratamiento
Anales de Pediatría, 2022 Resumen: Introducción: La talla baja es motivo de consulta frecuente en Endocrinología Pediátrica, precisando en ocasiones tratamiento con hormona del crecimiento (GH).
María José Sánchez Malo +6 more
doaj
Lipids in Health and Disease, 2018 Background Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and ...
Shuang Liang, Jiang Xue, Guimei Li
doaj +1 more source
Laron syndrome: An experience of treatment of two cases
Journal of Clinical and Translational Endocrinology Case Reports, 2021 Laron syndrome or growth hormone insensitivity is a rare disease presenting with severe postnatal growth failure. Clinically, in most circumstances, it is indistinguishable from growth hormone deficiency.
Hiya Boro +4 more
doaj